KLRA ▲ +1.2% - Kailera Therapeutics, Inc.
$KLRA reported Q3 2026 EPS of -$0.74, beating the -$1.12 estimate by 33.9%. Revenue was $0. No analyst estimate was published for revenue.
04-NOV-2026 06:00 PM ET
Share this post
More filings for $KLRA
KLRA ▲ +1.2% - Kailera Therapeutics, Inc.Nov 4, 2026KLRA ▲ +0.1% - Kailera Therapeutics, Inc.Nov 3, 2026KLRA ▲ +1.9% - Kailera Therapeutics, Inc.Sep 30, 2026KLRA - Kailera Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026KLRA SEC Filing Update (05-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 5, 2026
View full $KLRA filing history →💬 Comments
Loading comments…
Leave a comment